Angiocrine extracellular vesicles impose mesenchymal reprogramming upon proneural glioma stem cells.
Lata AdnaniJordan KassoufBrian MeehanCristiana SpinelliNadim TawilIchiro NakanoJanusz RakPublished in: Nature communications (2022)
Glioblastoma (GBM) is an incurable form of primary astrocytic brain tumor driven by glioma stem cell (GSC) compartment closely associated with the vascular niche. GSC phenotypes are heterogeneous and range from proneural to mesenchymal-like, the latter characterised by greater invasiveness. Here we document the secretory (angiocrine) role of endothelial cells and their derived extracellular vesicles (EVs) as drivers of proneural-to-mesenchymal reprogramming of GSCs. These changes involve activation of matrix metalloproteinases (MMPs) and NFκB, and inactivation of NOTCH, while altering responsiveness to chemotherapy and driving infiltrative growth in the brain. Our findings suggest that EV-mediated angiocrine interactions impact the nature of cellular stemness in GBM with implications for disease biology and therapy.
Keyphrases
- stem cells
- endothelial cells
- cell therapy
- bone marrow
- signaling pathway
- oxidative stress
- white matter
- resting state
- lps induced
- locally advanced
- multiple sclerosis
- pi k akt
- squamous cell carcinoma
- immune response
- high glucose
- epithelial mesenchymal transition
- functional connectivity
- cerebral ischemia
- subarachnoid hemorrhage
- cancer stem cells